Primary Site >> Colorectal Cancer

Gene >> TLR9

Journal: Clin Cancer Res. 2006 Jan 15;12(2):577-83.
Title: Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
Author: Damiano, Vincenzo|Caputo, Rosa|Bianco, Roberto|D'Armiento, Francesco P|Leonardi, Antonio|De Placido, Sabino|Bianco, A Raffaele|Agrawal, Sudhir|Ciardiello, Fortunato|Tortora, Giampaolo
PMID: 16428503
Journal: Int J Oncol. 2007 Jun;30(6):1511-9.
Title: Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
Author: Rayburn, Elizabeth R|Wang, Wei|Zhang, Ruiwen|Wang, Hui
PMID: 17487373
Journal: Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12468-73. Epub 2007 Jul 16.
Title: TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
Author: Damiano, Vincenzo|Caputo, Rosa|Garofalo, Sonia|Bianco, Roberto|Rosa, Roberta|Merola, Gerardina|Gelardi, Teresa|Racioppi, Luigi|Fontanini, Gabriella|De Placido, Sabino|Kandimalla, Ekambar R|Agrawal, Sudhir|Ciardiello, Fortunato|Tortora, Giampaolo
PMID: 17636117
Journal: Mol Cell Proteomics. 2008 Dec;7(12):2311-22.
Title: Comparative proteomics study reveals that bacterial CpG motifs induce tumor cell autophagy in vitro and in vivo.
Author: Bertin, Samuel|Samson, Michel|Pons, Catherine|Guigonis, Jean-Marie|Gavelli, Adolfo|Baque, Patrick|Brossette, Nicole|Pagnotta, Sophie|Ricci, Jean-Ehrland|Pierrefite-Carle, Valerie
PMID: 18632594
Journal: J Clin Invest. 2008 Nov;118(11):3751-61.
Title: CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.
Author: Roux, Stephan|Apetoh, Lionel|Chalmin, Fanny|Ladoire, Sylvain|Mignot, Gregoire|Puig, Pierre-Emmanuel|Lauvau, Gregoire|Zitvogel, Laurence|Martin, Francois|Chauffert, Bruno|Yagita, Hideo|Solary, Eric|Ghiringhelli, Francois
PMID: 18830416
Journal: J Immunol. 2009 Oct 1;183(7):4371-7.
Title: Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Author: Chiron, David|Pellat-Deceunynck, Catherine|Maillasson, Mike|Bataille, Regis|Jego, Gaetan
PMID: 19734228
Journal: Mol Cancer Ther. 2010 Jun;9(6):1788-97.
Title: Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
Author: Wang, Daqing|Precopio, Melissa|Lan, Tao|Yu, Dong|Tang, Jimmy X|Kandimalla, Ekambar R|Agrawal, Sudhir
PMID: 20515950
Journal: EMBO J. 2010 Jul 7;29(13):2242-52.
Title: TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.
Author: Mittal, Deepak|Saccheri, Fabiana|Venereau, Emilie|Pusterla, Tobias|Bianchi, Marco E|Rescigno, Maria
PMID: 20526283
Journal: Cancer Gene Ther. 2011 Dec;18(12):850-8.
Title: Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.
Author: Triozzi, P L|Aldrich, W|Ponnazhagan, S
PMID: 21869824
Journal: Cancer Res. 2011 Oct 15;71(20):6382-90.
Title: TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
Author: Sommariva, Michele|De Cecco, Loris|De Cesare, Michelandrea|Sfondrini, Lucia|Menard, Sylvie|Melani, Cecilia|Delia, Domenico|Zaffaroni, Nadia|Pratesi, Graziella|Uva, Valentina|Tagliabue, Elda|Balsari, Andrea
PMID: 21878529
Journal: Clin Cancer Res. 2011 Oct 15;17(20):6531-41.
Title: Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
Author: Rosa, Roberta|Melisi, Davide|Damiano, Vincenzo|Bianco, Roberto|Garofalo, Sonia|Gelardi, Teresa|Agrawal, Sudhir|Di Nicolantonio, Federica|Scarpa, Aldo|Bardelli, Alberto|Tortora, Giampaolo
PMID: 21890455
Journal: PLoS One. 2012;7(1):e29357.
Title: TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.
Author: Saha, Subhrajit|Bhanja, Payel|Liu, Laibin|Alfieri, Alan A|Yu, Dong|Kandimalla, Ekambar R|Agrawal, Sudhir|Guha, Chandan
PMID: 22238604
Journal: J Clin Immunol. 2012 Aug;32(4):848-54.
Title: Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.
Author: Eiro, Noemi|Gonzalez, Lucia|Gonzalez, Luis O|Andicoechea, Alejandro|Fernandez-Diaz, Maria|Altadill, Antonio|Vizoso, Francisco J
PMID: 22371291
Journal: Cancer Res. 2013 Dec 15;73(24):7211-21.
Title: TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.
Author: Gao, Chan|Kozlowska, Anna|Nechaev, Sergey|Li, Haiqing|Zhang, Qifang|Hossain, Dewan M S|Kowolik, Claudia M|Chu, Peiguo|Swiderski, Piotr|Diamond, Don J|Pal, Sumanta K|Raubitschek, Andrew|Kortylewski, Marcin
PMID: 24154870
Journal: World J Gastroenterol. 2013 Jul 14;19(26):4119-26.
Title: Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.
Author: Furi, Istvan|Sipos, Ferenc|Germann, Tiana M|Kalmar, Alexandra|Tulassay, Zsolt|Molnar, Bela|Muzes, Gyorgyi
PMID: 23864774
Journal: Oncol Rep. 2013 May;29(5):1737-43.
Title: The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Author: Nojiri, Keiichiro|Sugimoto, Kazushi|Shiraki, Katsuya|Tameda, Masahiko|Inagaki, Yuuji|Kusagawa, Satoko|Ogura, Suguru|Tanaka, Junichiro|Yoneda, Misao|Yamamoto, Norihiko|Okano, Hiroshi|Takei, Yoshiyuki|Ito, Masaaki|Kasai, Chika|Inoue, Hidekazu|Takase, Koujir
PMID: 23467704
Journal: J Immunother. 2013 Jul-Aug;36(6):342-9.
Title: Toll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancer.
Author: Eiro, Noemi|Gonzalez, Lucia|Gonzalez, Luis O|Fernandez-Garcia, Belen|Andicoechea, Alejandro|Barbon, Esther|Garcia-Muniz, Jose L|Vizoso, Francisco J
PMID: 23799413
Journal: PLoS One. 2014 May 2;9(5):e95847.
Title: Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice.
Author: Westwood, Jennifer A|Potdevin Hunnam, Titaina C U|Pegram, Hollie J|Hicks, Rodney J|Darcy, Phillip K|Kershaw, Michael H
PMID: 24788789
Journal: J Cancer Res Clin Oncol. 2014 Sep;140(9):1615-24.
Title: Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial.
Author: Schmoll, Hans-Joachim|Wittig, Burghardt|Arnold, Dirk|Riera-Knorrenschild, Jorge|Nitsche, Dieter|Kroening, Hendrik|Mayer, Frank|Andel, Johannes|Ziebermayr, Reinhard|Scheithauer, Werner
PMID: 24816725
Journal: World J Gastroenterol. 2014 May 21;20(19):5808-17.
Title: Intervention on toll-like receptors in pancreatic cancer.
Author: Vaz, Juan|Andersson, Roland
PMID: 24914341
Journal: Medicine (Baltimore). 2014 Dec;93(29):e349.
Title: IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9.
Author: Chang, Liang-Che|Fan, Chung-Wei|Tseng, Wen-Ko|Chein, Hui-Ping|Hsieh, Tsan-Yu|Chen, Jim-Ray|Hwang, Cheng-Cheng|Hua, Chung-Ching
PMID: 25546690
Journal: PLoS One. 2015 Jul 2;10(7):e0131699.
Title: Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.
Author: Furi, Istvan|Kalmar, Alexandra|Wichmann, Barnabas|Spisak, Sandor|Scholler, Andrea|Bartak, Barbara|Tulassay, Zsolt|Molnar, Bela
PMID: 26133168
Journal: Mol Cancer. 2015 May 15;14:104.
Title: X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes.
Author: Koo, Jung Eun|Shin, Seung Won|Um, Soong Ho|Lee, Joo Young
PMID: 25971982
Journal: Exp Ther Med. 2015 Apr;9(4):1455-1459.
Title: Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis.
Author: Fan, Yujing|Liu, Bingrong
PMID: 25780451
Journal: Eur J Cancer. 2015 Jan;51(2):146-56.
Title: Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Author: Weihrauch, Martin R|Richly, Heike|von Bergwelt-Baildon, Michael S|Becker, Hans Jiro|Schmidt, Manuel|Hacker, Ulrich T|Shimabukuro-Vornhagen, Alexander|Holtick, Udo|Nokay, Bahar|Schroff, Matthias|Wittig, Burghardt|Scheulen, Max E
PMID: 25480557
Journal: Biochem J. 2016 Jan 1;473(1):7-19.
Title: Co-operation of alpha-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.
Author: Dong, Tiangeng|Yi, Tuo|Yang, Mengxuan|Lin, Shengli|Li, Wenxiang|Xu, Xingyuan|Hu, Jianwei|Jia, Lijun|Hong, Xinqiang|Niu, Weixin
PMID: 26450924
Journal: Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7240-E7249.
Title: Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
Author: Wang, Shu|Campos, Jose|Gallotta, Marilena|Gong, Mei|Crain, Chad|Naik, Edwina|Coffman, Robert L|Guiducci, Cristiana
PMID: 27799536
Journal: Immun Inflamm Dis. 2016 Oct 18;4(4):446-462.
Title: Distinct immunological activation profiles of dSLIM(R) and ProMune(R) depend on their different structural context.
Author: Kapp, Kerstin|Schneider, Jacqueline|Schneider, Lisa|Gollinge, Nadine|Jansch, Stefanie|Schroff, Matthias|Wittig, Burghardt|Kleuss, Christiane
PMID: 27980779
Journal: Cancer Biomark. 2017;18(4):375-380.
Title: Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.
Author: Shahriari, Shadab|Rezaeifard, Somayeh|Moghimi, Hamid Reza|Khorramizadeh, Mohammad Reza|Faghih, Zahra
PMID: 28106541
Journal: PLoS One. 2018 Jun 8;13(6):e0197327.
Title: Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
Author: Messaritakis, Ippokratis|Stogiannitsi, Maria|Koulouridi, Asimina|Sfakianaki, Maria|Voutsina, Alexandra|Sotiriou, Afroditi|Athanasakis, Elias|Xynos, Evangelos|Mavroudis, Dimitris|Tzardi, Maria|Souglakos, John
PMID: 29883450
Journal: Nanoscale Res Lett. 2018 Aug 17;13(1):240.
Title: Modified Fe3O4 Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy.
Author: Zhang, Xueyan|Wu, Fengbo|Men, Ke|Huang, Rong|Zhou, Bailin|Zhang, Rui|Zou, Rui|Yang, Li
PMID: 30120629
Journal: Acta Biochim Biophys Sin (Shanghai). 2018 Sep 15. pii: 5098366.
Title: Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
Author: Niu, Zhengchuan|Tang, Wentao|Liu, Tianyu|Xu, Pingping|Zhu, Dexiang|Ji, Meiling|Huang, Wenbai|Ren, Li|Wei, Ye|Xu, Jianmin
PMID: 30239551
Journal: Onco Targets Ther. 2018 Sep 18;11:5963-5971.
Title: TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression.
Author: Gao, Caixia|Qiao, Tiankui|Zhang, Bin|Yuan, Sujuan|Zhuang, Xibing|Luo, Youjun
PMID: 30271180